Drugs / CAR-NK cells targeting NKG2D ligands
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03415100 | Jan 2018 → Dec 2019 | cancer | The Third Affiliated Hospital of Guangzhou Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-NK cells targeting NKG2D ligands | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03415100 ↗ |
| Modality | Cell therapy | “CAR-NK cell treatment” NCT03415100 ↗ |